CD21 and CD62L shedding are both inducible via P2X7Rs

International Immunology

Volumn 18, Issue 7, 2006, Pages 1171-1178

  Sengstake, Sarah ^a   Boneberg, Eva Maria ^b   Illges, Harald ^a,b  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b UNIVERSITY OF KONSTANZ   (Switzerland)

Author keywords

CD21; CD62L; Ectodomain shedding; KN62; oxATP; Purinergic receptors

Indexed keywords

ADENOSINE TRIPHOSPHATE DERIVATIVE; COMPLEMENT COMPONENT C3D RECEPTOR; MITOGENIC AGENT; PADGEM PROTEIN; PURINE P2X7 RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; LYMPHOCYTE MIGRATION; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION;

B-LYMPHOCYTES; CELL MOVEMENT; HUMANS; INFLAMMATION; L-SELECTIN; LYMPHOCYTE ACTIVATION; NEUTROPHILS; PROTO-ONCOGENE PROTEINS C-BCR; RECEPTORS, COMPLEMENT 3D; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION;

EID: 33745285783     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxl051     Document Type: Article

References (41)

1. Dello Sbarba, P. and Rovida, E. 2002. Transmodulation of cell surface regulatory molecules via ectodomain shedding. Biol. Chem. 383:69.
2. Gearing, A. J. and Newman, W. 1993. Circulating adhesion molecules in disease. Immunol. Today 14:506.
3. Tedder, T. F., Steeber, D. A. and Pizcueta, P. 1995. L-selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites. J. Exp. Med. 181:2259.
4. Steeber, D. A., Green, N. E., Sato, S. and Tedder, T. F. 1996. Humoral immune responses in L-selectin-deficient mice. J. Immunol. 157:4899.
5. Venturi, G. M., Tu, L., Kadono, T. et al. 2003. Leukocyte migration is regulated by L-selectin endoproteolytic release. Immunity 19:713.
6. Jamieson, G. P., Snook, M. B., Thurlow, P. J. and Wiley, J. S. 1996. Extracellular ATP causes loss of L-selectin from human lymphocytes via occupancy of P2Z purinocepters. J. Cell. Physiol. 166:637.
7. Gu, B., Bendall, L. J. and Wiley, J. S. 1998. Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases. Blood 92:946.
8. Wroblewski, M. and Hamann, A. 1997. CD45-mediated signals can trigger shedding of lymphocyte L-selectin. Int. Immunol. 9:555.
9. Ager, A. 1994. Lymphocyte recirculation and homing: Roles of adhesion molecules and chemoattractants. Trends Cell Biol. 4:326.
10. Gomez-Gaviro, M. V., Dominguez-Jimenez, C., Carretero, J. M. et al. 2000. Down-regulation of L-selectin expression in neutrophils by nonsteroidal anti-inflammatory drugs: Role of intracellular ATP concentration. Blood 96:3592.
11. Walcheck, B., Kahn, J., Fisher, J. M. et al. 1996. Neutrophil rolling altered by inhibition of L-selectin shedding in vitro. Nature 380:720.
12. Kaba, N. K. and Knauf, P. A. 2001. Hypotonicity induces L-selectin shedding in human neutrophils. Am. J. Physiol. Cell Physiol. 281:C1403.
13. Berg, M. and James, S. P. 1990. Human neutrophils release the Leu-8 lymph node homing receptor during cell activation. Blood 76:2381.
14. Walcheck, B., Alexander, S. R., St Hill, C. A. and Matala, E. 2003. ADAM-17-independent shedding of L-selectin. J. Leukoc. Biol. 74:389.
15. Borland, G., Murphy, G. and Ager, A. 1999. Tissue inhibitor of metalloproteinases-3 inhibits shedding of L-selectin from leukocytes. J. Biol. Chem. 274:2810.
16. Feehan, C., Darlak, K., Kahn, J., Walcheck, B., Spatola, A. F. and Kishimoto, T. K. 1996. Shedding of the lymphocyte L-selectin adhesion molecule is inhibited by a hydroxamic acid-based protease inhibitor. Identification with an L-selectin-alkaline phosphatase reporter. J. Biol. Chem. 271:7019.
17. Chessell, I. P., Michel, A. D. and Humphrey, P. P. 2001. P2X receptors. In Abbracchio, M. P. and Williams, M., eds, Purinergic and Pyrimidinergic Signalling I, p. 47. Springer Verlag Berlin Heidelberg New York.
18. Budagian, V., Bulanova, E., Brovko, L. et al. 2003. Signaling through P2X7 receptor in human T cells involves p56lck, MAP kinases, and transcription factors AP-1 and NF-kappa B. J. Biol. Chem. 278:1549.
19. Gu, B. J., Zhang, W. Y., Bendall, L. J., Chessell, I. P., Buell, G. N. and Wiley, J. S. 2000. Expression of P2X(7) purinoceptors on human lymphocytes and monocytes: Evidence for nonfunctional P2X(7) receptors. Am. J. Physiol. Cell Physiol. 279:C1189.
20. Labasi, J. M., Petrushova, N., Donovan, C. et al. 2002. Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J. Immunol. 168:6436.
21. Pearson, J. D., Coade, S. B. and Cusack, N. J. 1985. Characterization of ectonucleotidases on vascular smooth-muscle cells. Biochem. J. 230:503.
22. Bodin, P. and Burnstock, G. 1998. Increased release of ATP from endothelial cells during acute inflammation. Inflamm. Res. 47:351.
23. Robson, S. C., Kaczmarek, E., Siegel, J. B. et al. 1997. Loss of ATP diphosphohydrolase activity with endothelial cell activation. J. Exp. Med. 185:153.
24. Zheng, L. M., Zychlinsky, A., Liu, C. C., Ojcius, D. M. and Young, J. D. 1991. Extracellular ATP as a trigger for apoptosis or programmed cell death. J. Cell Biol. 112:279.
25. Casola, S., Otipoby, K. L., Alimzhanov, M. et al. 2004. B cell receptor signal strength determines B cell fate. Nat. Immunol. 5:317.
26. Chakravarty, L., Zabel, M. D., Weis, J. J. and Weis, J. H. 2002. Depletion of Lyn kinase from the BCR complex and inhibition of B cell activation by excess CD21 ligation. Int. Immunol. 14:139.
27. Cherukuri, A., Cheng, P. C. and Pierce, S. K. 2001. The role of the CD19/ CD21 complex in B cell processing and presentation of complement-tagged antigens. J. Immunol. 167:163.
28. Hasler, P. and Zouali, M. 2001. B cell receptor signaling and autoimmunity. Faseb J. 15:2085.
29. Masilamani, M., von Kempis, J. and Illges, H. 2004. Decreased levels of serum soluble complement receptor-II (CR2/CD21) in patients with rheumatoid arthritis. Rheumatology (Oxford) 43:186.
30. Masilamani, M., Kassahn, D., Mikkat, S., Glocker, M. O. and Illges, H. 2003. B cell activation leads to shedding of complement receptor type II (CR2/CD21). Eur. J. Immunol. 33:2391.
31. Vandesompele, J., De Preter, K., Pattyn, F. et al. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3:RESEARCH0034.
32. Peschon, J. J., Slack, J. L., Reddy, P. et al. 1998. An essential role for ectodomain shedding in mammalian development. Science 282:1281.
33. Aichem, A., Masilamani, M. and H. Illges. 2006. Redox-regulation of CD21 shedding involves signaling via PKC and indicates the formation of a juxtamembrane stalk. J. Cell Sci., in press.
34. Michel, A. D., Kaur, R., Chessell, I. P. and Humphrey, P. P. 2000. Antagonist effects on human P2X(7) receptor-mediated cellular accumulation of YO-PRO-1. Br. J. Pharmacol. 130:513.
35. Sallusto, F., Lenig, D., Forster, R., Lipp, M. and Lanzavecchia, A. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708.
36. Roberts, A. D. and Woodland, D. L. 2004. Cutting edge: Effector memory CD8+ T cells play a prominent role in recall responses to secondary viral infection in the lung. J. Immunol. 172:6533.
37. Kraal, G., Weissman, I. L. and Butcher, E. C. 1988. Memory B cells express a phenotype consistent with migratory competence after secondary but not short-term primary immunization. Cell. Immunol. 115:78.
38. Schleiffenbaum, B., Spertini, O. and Tedder, T. F. 1992. Soluble L-selectin is present in human plasma at high levels and retains functional activity. J. Cell Biol. 119:229.
39. Kahn, J., Ingraham, R. H., Shirley, F., Migaki, G. I. and Kishimoto, T. K. 1994. Membrane proximal cleavage of L-selectin: Identification of the cleavage site and a 6-kD transmembrane peptide fragment of L-selectin. J. Cell Biol. 125:461.
40. Weis, J. J., Toothaker, L. E., Smith, J. A., Weis, J. H. and Fearon, D. T. 1988. Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/ C4 binding proteins. J. Exp. Med. 167:1047.
41. Fremeaux-Bacchi, V., Fischer, E., Lecoanet-Henchoz, S., Mani, J. C., Bonnefoy, J. Y. and Kazatchkine, M. D. 1998. Soluble CD21 (sCD21) forms biologically active complexes with CD23: SCD21 is present in normal plasma as a complex with trimeric CD23 and inhibits soluble CD23-induced IgE synthesis by B cells. Int. Immunol. 10:1459.